![](https://investorshub.advfn.com/uicon/84558.png?cb=1466123205)
Tuesday, October 28, 2014 9:20:27 PM
No they're not. They're being "printed" by a high roller with market maker trading privileges. I would estimate, over 90%, anyway. A market maker can sell as many pseudo shares as he wants, "to provide liquidity" - which is why they get to do that. This is also called "naked shorting" - there are no actual shares being borrowed and sold. He only has to indicate that he knows where to get them (can you guess where). They have 14 days, according to the rules, otherwise, they get slapped ( lightly on the wrist, at least, historically) with a "failure to deliver". They still don't have to cover though.
A retail short position over $5 has to involve actual borrowed shares and you get charged interest, like on any loan, so there is a string incentive to cover at some point, but the high roller with mm power doesn't have the same constraints.
As a retail US investor, I'm not allowed to short stocks with a pps under $5, so, the ridiculously high volumes going down are not from retail. A typical agenda for the high roller/hedge fund (perhaps with loan shark cohorts) is to drive a small indebted company into bankruptcy, in which case, they never have to cover. Also possible, if the company is a target for hostile takeover, it is way to get to get a big discount on the share price ahead of time.
Another thing possibly indicated by ridiculously huge volumes is a "walk-down" wherein , basically, the left hand (of basically the same entity) sells to the right hand, then vice-versa, adjusting the pps as they go. With an occasional dump to hammer down a pesky bump here and there. It doesn't cost them any money, they've already got a bundle of cash from selling all the naked short shares going into the national crisis news generated public speculative interest peak.
The reason bashers appear is to destroy "good will" - which is an actual accounting entry based on public perception of future pps performance, or, in other words, to create a "good will impairment", the goal of the negative publicity. Retail generally can't stop the process, but they can muck up the operation a bit, which is why they are being attended to by the minion trolls, on the various message boards, while the naked shorting swamps out the remaining calculated retail volume.
If we're lucky, it may be that it may be a more simple form of manipulation and it will be allowed to run again at some point, which is possible, given that the company is likely to do very well in the upcoming climate of developing events.
Recent IBIO News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 08:02:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:10:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:08:04 PM
- iBio Closes Sale of Manufacturing Facility in Texas • GlobeNewswire Inc. • 06/03/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 10:55:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:32:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:30:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:14:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:08:29 PM
- iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2024 08:05:00 PM
- iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases • GlobeNewswire Inc. • 03/27/2024 11:00:00 AM
- iBio Announces $15.0 Million Private Placement • GlobeNewswire Inc. • 03/26/2024 11:35:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:59:30 PM
- iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka • GlobeNewswire Inc. • 02/26/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:55:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:36:09 PM
- iBio Announces Participation in 23rd Annual PepTalk Conference • GlobeNewswire Inc. • 01/16/2024 01:15:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/10/2024 06:24:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:30:59 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/04/2024 01:00:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 12:44:38 PM
- iBio Amends and Extends Maturity of Credit Agreement • GlobeNewswire Inc. • 12/26/2023 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:17:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 02:13:08 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/06/2023 01:59:51 PM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM